A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
8/7/2026
BreakingDealsDry EyePharmaRetina
Tarsus to Acquire Alkeus Pharmaceuticals in Deal Worth up to $800 Million
Tarsus Pharmaceuticals, maker of Xdemvy, announced Aug. 6 that it would acquire Alkeus Pharmaceuticals in a cash-and-stock deal worth up to $800 million. Under the deal, Tarsus will pay $450 milli...
8/7/2026
BiosimilarsBreakingCataractIOLLaserPharmaRetinaRevenueSurgicalThyroid Eye Disease
Q2-2026 Ophthalmic Revenue Roundup for Regeneron, Amgen, Hoya, Astellas, Novartis, Lumibird, Ocular Therapeutix, and Xbrane
Regeneron, of Tarrytown, New York, reported July 30 that its Q2-2026 US revenue for Eylea HD and Eylea 2 mg was $1.0 billion, a 12 percent decrease from $1.15 billion in Q2-2025. Eylea HD accounted...
8/7/2026
BiosimilarsBreakingRetina
Biocon Launches Eylea Biosimilar Yesafili in the US
India’s Biocon Limited announced on Aug. 3 the commercial launch of Yesafili (aflibercept-jbvf), a biosimilar to Eylea 2 mg, in the US. Yesafili was among a flurry of Eylea biosimilars approved by ...
8/7/2026
BreakingDealsDry EyePharma
Harrow Acquires Global Rights to Tyrvaya Nasal Spray for Dry Eye
Harrow, of Nashville, Tennessee, announced Aug. 6 that it would acquire global rights to Tyrvaya (varenicline) nasal spray for dry eye from Viatris. Under the deal, Harrow will pay $30 million up f...
8/7/2026
BreakingDeviceGlaucomaMIGSRegulation
Sight Sciences Gains US FDA 510(k) Clearance for Omni Ultra Glaucoma Device
Sight Sciences announced Aug. 4 that it had gained 510(k) clearance from the US FDA for the Omni Ultra surgical system. Sight Sciences, of Menlo Park, California, said the Ultra is indicated for ca...
8/7/2026
BreakingDiagnosticEuropeFundusRegulation
Topcon Gains CE Marking for Gaia Ultra-widefield Retinal Imager
Topcon Healthcare announced July 17 that it had gained CE marking in Europe for its Gaia ultra-widefield retinal imaging device. Topcon says Gaia offers true-color fundus imaging, with a 209-degree...
8/7/2026
BreakingIndiaIndustryRetinaSurgical
Aravind, Alcon Open Centre of Excellence for Vitreoretinal Surgery Training in India
Aravind Eye Care System and Alcon reported July 24 that they had launched the Aravind Alcon Global Centre of Excellence for Vitreoretinal Surgery Training in Coimbatore, India. The move marks the s...
8/7/2026
BreakingIndustryRefractiveSurgical
STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer
STAAR Surgical, of Lake Forest, California, reported Aug. 4 that it had appointed Warren Foust as president and chief executive officer. Foust and Deborah Andrews, STAAR’s chief financial officer, ...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.